Avacta Group PLC (LSE:AVCT) - Overview

Stock Report

Avacta Group PLC AVCT

Last Price
GBX78.05

Day Change
-1.95|-2.44%

As of 06/12/2016
10:05:55 GMT | GBX
Minimum 15 Minutes Delay.

Last Close80.00p
Day Range78.05 - 78.05
Mkt Cap54.71Mil
52-Wk Range78.00 - 134.30
Yield %0.00
ISINGB00BYYW9G87
Volume140
P/E-11.54
P/S24.41
P/CF-12.49

Share Price

Total Returns 05/12/2016

 Chg (%)  
More ...
Avacta Group PLC-14.89 
FTSE 100 TR GBP1.22
 
Financials
201420152016
More ...
Income Statement
Turnover1.621.812.17
Operating Profit-2.05-5.57-5.66
Net Profit-1.47-4.89-4.65
Reported EPS-4.00-20.10-6.86
Balance Sheet
Current Assets13.369.5022.34
Non Current Assets17.6911.9115.22
Total Assets31.0521.4037.55
Current Liabilities1.741.801.67
Total Liabilities2.212.271.70
Total Equity28.8419.1335.86
Cash Flow
Operating Cash Flow-1.28-0.34-4.90
Net Change in Cash10.90-4.152.19
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-7.62-8.90--8.99---
2018-8.52-9.86--8.11---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/10/2016PurchaseDr. Mike Owen90.007,7636,987.00
13/07/2016PurchaseDr. Michael Albin92.103,3933,125.00
29/04/2016PurchaseMr. Craig Slater112.502,2222,500.00
12/04/2016PurchaseDr. Michael Albin115.808991,041.00

Company Profile

Avacta Group PLC is engaged in research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology.
 

Sector

Medical Devices

Market Position

1054 of 1864 Companies

Index

FTSE AIM All Share

Outlook

(01/12/2016) ch - "...we are extremely optimistic about 2017"

Next Event 20/01/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)-8.6613.5916.10
Div Yld (E)0.004.234.35
PEG (E)0.000.550.19
ROCE-22.56209.79-30.25
Op Mrgn-258.52-15.64-33.57
EPS Grwth0.008.6822.86
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Trevor Nicholls
Chief ExecutiveProf Alastair Smith
Chief Financial Officer & Company SecretTony Gardiner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.